Pfizer signs deal to allow other companies to produce its Covid-19 pill

pfizer signs deal to allow other companies to produce its covid 19 pill

Sumary of Pfizer signs deal to allow other companies to produce its Covid-19 pill:

  • In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population.
  • The deal excludes some large countries that have suffered devastating coronavirus outbreaks.
  • “It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
  • Earlier this month, Pfizer said its pill cut the risk of hospitalization and death by nearly 90% in people with mild to moderate coronavirus infections.
  • Independent experts recommended halting the company’s study based on its promising results.
  • In a similar deal with the Medicines Patent Pool announced in October, Merck agreed to let other drugmakers make its Covid-19 pill, molnupiravir, available in 105 poorer countries.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close